首页> 外国专利> Crystalline hydrochloride salt of 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-(R)-2-hydroxy-3-(methanesulfonyl-methyl-amino)propyl-8-azabicyclo3.2.1oct-3-yl}amide

Crystalline hydrochloride salt of 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-(R)-2-hydroxy-3-(methanesulfonyl-methyl-amino)propyl-8-azabicyclo3.2.1oct-3-yl}amide

机译:1-异丙基-2-氧代-1,2-二氢喹啉-3-羧酸{(1S,3R,5R)-8-[(R)-2-羟基-3-(甲磺酰基-甲基-氨基) ]丙基] -8-氮杂双环[3.2.1]辛-3-基}酰胺

摘要

Disclosed is a crystalline salt form which is the hydrochloride salt of 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[(R)-2-hydroxy-3-(methanesulfonyl-methyl-amino)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide or a solvate thereof. Also disclosed is the use of a crystalline salt form as defined above for manufacture of a medicament for the treatment of a medical condition in a mammal associated with 5-HT4 receptor activity (including disorders of reduced motility of the gastrointestinal tract, chronic constipation, constipation-predominant irritable bowel syndrome, diabetic and idiopathic gastroparesis, and functional dyspepsia).
机译:公开了一种结晶盐形式,其是1-异丙基-2-氧代-1,2-二氢喹啉-3-羧酸{(1S,3R,5R)-8-[(R)-2-羟基- 3-(甲磺酰基-甲基-氨基)丙基] -8-氮杂双环[3.2.1]辛-3-基}酰胺或其溶剂化物。还公开了如上所定义的结晶盐形式在制备用于治疗与5-HT 4受体活性(包括胃肠道运动性降低,慢性便秘,便秘的疾病)有关的哺乳动物的医学病症的药物中的用途。 -肠易激综合征,糖尿病和特发性胃轻瘫和功能性消化不良)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号